Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Kazakh National Medical University

Nom variantlari: KazNMU · Kazakh National Medical University named after S.D. Asfendiyarov · Казахский национальный медицинский университет имени С. Д. Асфендиярова · Қазақ ұлттық медицина университеті

Davlat:
KZ
ROR:
https://ror.org/05pc6w891
3
h-indeks
59
Iqtiboslar
144
Asarlar
238
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0132538500510152020172018201920202021202220232024202520262017: Nashrlar 1, Iqtiboslar 12018: Nashrlar 3, Iqtiboslar 12019: Nashrlar 4, Iqtiboslar 02020: Nashrlar 7, Iqtiboslar 42021: Nashrlar 10, Iqtiboslar 62022: Nashrlar 4, Iqtiboslar 42023: Nashrlar 13, Iqtiboslar 82024: Nashrlar 18, Iqtiboslar 142025: Nashrlar 33, Iqtiboslar 122026: Nashrlar 45, Iqtiboslar 6

Iqtibos tarixi

0510152020172018201920202021202220232024202520262017: Iqtiboslar 12018: Iqtiboslar 12019: Iqtiboslar 02020: Iqtiboslar 42021: Iqtiboslar 62022: Iqtiboslar 42023: Iqtiboslar 82024: Iqtiboslar 142025: Iqtiboslar 122026: Iqtiboslar 6

Nashr tarixi

01325385020172018201920202021202220232024202520262017: Nashrlar 12018: Nashrlar 32019: Nashrlar 42020: Nashrlar 72021: Nashrlar 102022: Nashrlar 42023: Nashrlar 132024: Nashrlar 182025: Nashrlar 332026: Nashrlar 45

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520172018201920202021202220232024202520262017: h-indeks 12018: h-indeks 12019: h-indeks 12020: h-indeks 22021: h-indeks 22022: h-indeks 32023: h-indeks 32024: h-indeks 32025: h-indeks 32026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up20213 iqtibos
  2. High incidence of rheumatic fever and Rheumatic heart disease in the republics of Central Asia20092 iqtibos
  3. Increasing autoimmune rheumatic diseases as a consequence of the <scp>COVID</scp>‐19 pandemic: A hypothesis or fact?20232 iqtibos
  4. Rethinking priorities in hospital management: a case from Central Asia20201 iqtibos
  5. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease20211 iqtibos
  6. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–201720211 iqtibos
  7. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)20211 iqtibos
  8. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment20231 iqtibos
  9. Diversity of kidney care referral pathways in national child health systems of 48 European countries20241 iqtibos
  10. Lumbar total disk replacement versus microsurgical lumbar discectomy in treatment of radicular and back pain in railway workers: a prospective randomized controlled trial20241 iqtibos